IDEAS logo
IDEAS-lightbulb

IDEAS welcomes AstraZeneca to our H2020 project

IDEAS would like to welcome AstraZeneca to our innovative training network as a partner.

Project spotlight:

3. Using pre-clinical information to establish a safe dose in first-in-men studies

Before a novel compound is evaluated in a series of clinical trials, a number of pre-clinical, in-vitro and in-vivo studies are typically undertaken.

[ see all projects ]